Clinical characteristics and treatment of actinomycetoma in northeast Mexico: A case series.

Jesus A Cardenas-de la GarzaOliverio WelshAdrian B Cuellar-BarbozaKarina Paola Suarez-SánchezEstephania De la Cruz-ValadezLuis Gerardo Cruz-GómezAnabel Gallardo-RochaJorge Ocampo-CandianiLucio Vera-Cabrera

Published in: PLoS neglected tropical diseases (2020)

In our sample, actinomycetoma was predominantly caused by N. brasiliensis. Most cases responded well to therapy with a combination of TMP/SMX with amikacin or TMP/SMX and amoxicillin/clavulanic acid. Four patients required multiple antibiotics and intrahospital care.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
healthcare
chronic kidney disease
peritoneal dialysis
stem cells
quality improvement
replacement therapy
cell therapy